Abstract
The “outer” SVARAD dimensions, impulsivity, anger/aggressiveness, and activation, represent trans-diagnostic psychological and behavioural domains that span traditional categorical boundaries. At the neurobiological level, the fronto-limbic and the fronto-cerebellar circuitry, as well as molecular pathways involving dopamine, serotonin, testosterone, and inflammatory mediators, play a crucial role in mediating the biological underpinnings of these psychopathological dimensions. From a clinical perspective, as the combination of clusters of symptoms differs from patient to patient and gives rise to a wide variety of clinical pictures even among subjects with the same diagnosis, it is important that the clinical features related to impulsivity, anger, aggressiveness, and activation are specifically and multiparametrically investigated and treated. The aim of the present chapter is to discuss the psychopathological aspects, the neurobiological underpinnings, and the clinical implications related to the “outer dimensions” in clinical psychiatry.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Washington, DC: American Psychiatric Association; 2013.
Moeller FG, et al. Psychiatric aspects of impulsivity. Am J Psychiatry. 2001;158(11):1783–93.
Biondi M, Pasquini M. Dimensional psychopharmacology of the cancer patient. In: Biondi M, Costantini A, Wise TN, editors. Psycho-oncology. Arlington, VA: American Psychiatric Publishing; 2013.
Pancheri P, et al. Costruzione della “SVARAD”, una scala per la valutazione rapida dimensionale. Rivista di Psichiatria. 1999;34:72–83.
Turecki G. Dissecting the suicide phenotype: the role of impulsive-aggressive behaviours. J Psychiatry Neurosci. 2005;30(6):398–408.
Hollander E, Rosen J. Impulsivity. J Psychopharmacol. 2000;14(2 Suppl 1):S39–44.
Insel T, et al. Research domain criteria (RDoC): toward a new classification framework for research on mental disorders. Am J Psychiatry. 2010;167(7):748–51.
Oldham JM, Hollander E, Skodol AE. Impulsivity and compulsivity. Arlington, VA: American Psychiatric Publishing; 1996.
Berlin HA, Hollander E. Understanding the differences between impulsivity and compulsivity. Psychiatric Times, 2008;25(8). http://www.psychiatrictimes.com/impulse-control-disorders/understanding-differences-betweenimpulsivity-and-compulsivity.
Spielberger CD, Sarason IG. Stress and emotion. Didcot: Taylor & Francis; 1995.
Ekman P. An argument for basic emotions. Cognit Emot. 1992;6:169–200.
Berkowitz L, Harmon-Jones E. Toward an understanding of the determinants of anger. Emotion. 2004;4(2):107–30.
Lee AH, DiGiuseppe R. Anger and aggression treatments: a review of meta-analyses. Curr Opin Psychol. 2018;19:65–74.
Vitiello B, Stoff DM. Subtypes of aggression and their relevance to child psychiatry. J Am Acad Child Adolesc Psychiatry. 1997;36(3):307–15.
Biondi M, et al. Dimensional psychopathology of depression: detection of an ‘activation’ dimension in unipolar depressed outpatients. J Affect Disord. 2005;84(2–3):133–9.
Day RK. Psychomotor agitation: poorly defined and badly measured. J Affect Disord. 1999;55(2–3):89–98.
Carroll BJ. Psychopathology and neurobiology of manic-depressive disorders. In: Carroll BJ, Barrett JE, editors. Psychopathology and the Brain. New York: Raven Press; 1991.
Siever LJ. Neurobiology of aggression and violence. Am J Psychiatry. 2008;165(4):429–42.
Blair RJ. The roles of orbital frontal cortex in the modulation of antisocial behavior. Brain Cogn. 2004;55(1):198–208.
Frith C, Dolan R. The role of the prefrontal cortex in higher cognitive functions. Brain Res Cogn Brain Res. 1996;5(1–2):175–81.
Beck A, Heinz A. Alcohol-related aggression-social and neurobiological factors. Dtsch Arztebl Int. 2013;110(42):711–5.
Yudofsky SC, Silver JM, Hales RE. Cocaine and aggressive behavior: neurobiological and clinical perspectives. Bull Menn Clin. 1993;57(2):218–26.
Frazzetto G, et al. Early trauma and increased risk for physical aggression during adulthood: the moderating role of MAOA genotype. PLoS One. 2007;2(5):e486.
Sansone RA, Leung JS, Wiederman MW. Five forms of childhood trauma: relationships with aggressive behavior in adulthood. Prim Care Companion CNS Disord. 2012;14(5). https://doi.org/10.4088/PCC.12m01353.
Dambacher F, et al. Reducing proactive aggression through non-invasive brain stimulation. Soc Cogn Affect Neurosci. 2015;10(10):1303–9.
Philipp-Wiegmann F, et al. Reduced cortical inhibition in violent offenders: a study with transcranial magnetic stimulation. Neuropsychobiology. 2011;64(2):86–92.
Riva P, et al. Reducing aggressive responses to social exclusion using transcranial direct current stimulation. Soc Cogn Affect Neurosci. 2015;10(3):352–6.
Thiebaut de Schotten M, et al. From Phineas Gage and Monsieur Leborgne to H.M.: Revisiting disconnection syndromes. Cereb Cortex. 2015;25(12):4812–27.
Harlow J. Recovery from the passage of an iron bar through the head. Publ Mass Med Soc. 1868;2:327–47.
Nicholl J, LaFrance WC Jr. Neuropsychiatric sequelae of traumatic brain injury. Semin Neurol. 2009;29(3):247–55.
Hazlett EA, et al. Reduced anterior and posterior cingulate gray matter in borderline personality disorder. Biol Psychiatry. 2005;58(8):614–23.
Raine A, et al. Hippocampal structural asymmetry in unsuccessful psychopaths. Biol Psychiatry. 2004;55(2):185–91.
Donegan NH, et al. Amygdala hyperreactivity in borderline personality disorder: implications for emotional dysregulation. Biol Psychiatry. 2003;54(11):1284–93.
Gobrogge KL, et al. Anterior hypothalamic neural activation and neurochemical associations with aggression in pair-bonded male prairie voles. J Comp Neurol. 2007;502(6):1109–22.
Goyer PF, et al. Positron-emission tomography and personality disorders. Neuropsychopharmacology. 1994;10(1):21–8.
Herpertz SC, et al. Evidence of abnormal amygdala functioning in borderline personality disorder: a functional MRI study. Biol Psychiatry. 2001;50(4):292–8.
Koenigsberg HW, et al. Neural correlates of emotion processing in borderline personality disorder. Psychiatry Res. 2009;172(3):192–9.
Catani M, et al. Beyond cortical localization in clinico-anatomical correlation. Cortex. 2012;48(10):1262–87.
Spencer TJ, et al. Overview and neurobiology of attention-deficit/hyperactivity disorder. J Clin Psychiatry. 2002;63(Suppl 12):3–9.
Barkley RA. ADHD and the nature of self-control. New York: Guilford Press; 1997.
Minichino A, et al. The role of cerebellum in unipolar and bipolar depression: a review of the main neurobiological findings. Riv Psichiatr. 2014;49(3):124–31.
Strick PL, Dum RP, Fiez JA. Cerebellum and nonmotor function. Annu Rev Neurosci. 2009;32:413–34.
King JA, et al. Neural substrates underlying impulsivity. Ann N Y Acad Sci. 2003;1008:160–9.
Lee AK, et al. Neural correlates of impulsivity factors in psychiatric patients and healthy volunteers: a voxel-based morphometry study. Brain Imaging Behav. 2011;5(1):52–64.
Moers-Hornikx VM, et al. Cerebellar nuclei are involved in impulsive behaviour. Behav Brain Res. 2009;203(2):256–63.
Schmahmann JD, Sherman JC. The cerebellar cognitive affective syndrome. Brain. 1998;121(Pt 4):561–79.
Schmahmann JD, Weilburg JB, Sherman JC. The neuropsychiatry of the cerebellum - insights from the clinic. Cerebellum. 2007;6(3):254–67.
Curatolo P, D'Agati E, Moavero R. The neurobiological basis of ADHD. Ital J Pediatr. 2010;36(1):79.
Miles DR, Carey G. Genetic and environmental architecture of human aggression. J Pers Soc Psychol. 1997;72(1):207–17.
Meyer-Lindenberg A, et al. Neural mechanisms of genetic risk for impulsivity and violence in humans. Proc Natl Acad Sci U S A. 2006;103(16):6269–74.
Brunner HG, et al. Abnormal behavior associated with a point mutation in the structural gene for monoamine oxidase A. Science. 1993;262(5133):578–80.
Cases O, et al. Aggressive behavior and altered amounts of brain serotonin and norepinephrine in mice lacking MAOA. Science. 1995;268(5218):1763–6.
Kim JJ, et al. Selective enhancement of emotional, but not motor, learning in monoamine oxidase A-deficient mice. Proc Natl Acad Sci U S A. 1997;94(11):5929–33.
Deater-Deckard K, et al. Multiple risk factors in the development of externalizing behavior problems: group and individual differences. Dev Psychopathol. 1998;10(3):469–93.
Fergusson DM, Lynskey MT. Physical punishment/maltreatment during childhood and adjustment in young adulthood. Child Abuse Negl. 1997;21(7):617–30.
Marks DJ, et al. The interaction of psychosocial adversity and biological risk in childhood aggression. Psychiatry Res. 2007;151(3):221–30.
Kim-Cohen J, et al. MAOA, maltreatment, and gene-environment interaction predicting children's mental health: new evidence and a meta-analysis. Mol Psychiatry. 2006;11(10):903–13.
Reif A, et al. Nature and nurture predispose to violent behavior: serotonergic genes and adverse childhood environment. Neuropsychopharmacology. 2007;32(11):2375–83.
Linnoila M, et al. Low cerebrospinal fluid 5-hydroxyindoleacetic acid concentration differentiates impulsive from nonimpulsive violent behavior. Life Sci. 1983;33(26):2609–14.
Brunner D, Hen R. Insights into the neurobiology of impulsive behavior from serotonin receptor knockout mice. Ann N Y Acad Sci. 1997;836:81–105.
Davidge KM, et al. Association of the serotonin transporter and 5HT1Dbeta receptor genes with extreme, persistent and pervasive aggressive behaviour in children. Psychiatr Genet. 2004;14(3):143–6.
Mik HM, et al. Serotonin system genes and childhood-onset aggression. Psychiatr Genet. 2007;17(1):11.
Courtet P, et al. Association between violent suicidal behavior and the low activity allele of the serotonin transporter gene. Mol Psychiatry. 2001;6(3):338–41.
Potenza MN. How central is dopamine to pathological gambling or gambling disorder? Front Behav Neurosci. 2013;7:206.
Seo D, Patrick CJ, Kennealy PJ. Role of serotonin and dopamine system interactions in the neurobiology of impulsive aggression and its comorbidity with other clinical disorders. Aggress Violent Behav. 2008;13(5):383–95.
Daw ND, Kakade S, Dayan P. Opponent interactions between serotonin and dopamine. Neural Netw. 2002;15(4–6):603–16.
Ferrari PF, et al. Accumbal dopamine and serotonin in anticipation of the next aggressive episode in rats. Eur J Neurosci. 2003;17(2):371–8.
van Erp AM, Miczek KA. Aggressive behavior, increased accumbal dopamine, and decreased cortical serotonin in rats. J Neurosci. 2000;20(24):9320–5.
Brain PF. Hormonal aspects of aggression and violence. In: N.R. Council, editor. Understanding and preventing violence, Biobehavioral influences, vol. 2. Washington, DC: The National Academies Press; 1994.
Fetissov SO, et al. Aggressive behavior linked to corticotropin-reactive autoantibodies. Biol Psychiatry. 2006;60(8):799–802.
Gower AL, Crick NR. Baseline autonomic nervous system arousal and physical and relational aggression in preschool: the moderating role of effortful control. Int J Psychophysiol. 2011;81(3):142–51.
Zalcman SS, Siegel A. The neurobiology of aggression and rage: role of cytokines. Brain Behav Immun. 2006;20(6):507–14.
Coccaro EF, Lee R, Coussons-Read M. Cerebrospinal fluid inflammatory cytokines and aggression in personality disordered subjects. Int J Neuropsychopharmacol. 2015;18(7):pyv001.
Coccaro EF, Lee R, Coussons-Read M. Elevated plasma inflammatory markers in individuals with intermittent explosive disorder and correlation with aggression in humans. JAMA Psychiat. 2014;71(2):158–65.
Dazzi F, et al. Predictors of inpatient psychiatric admission in patients presenting to the emergency department: the role of dimensional assessment. Gen Hosp Psychiatry. 2015;37(6):587–94.
Tomko RL, et al. Measuring impulsivity in daily life: the momentary impulsivity scale. Psychol Assess. 2014;26(2):339–49.
Patton JH, Stanford MS, Barratt ES. Factor structure of the Barratt impulsiveness scale. J Clin Psychol. 1995;51(6):768–74.
Pancheri P, et al. Validazione della scala per la valutazione rapida dimensionale “SVARAD”. Riv Psichiatr. 1999;34:84–93.
Sunohara GA, et al. Effect of methylphenidate on attention in children with attention deficit hyperactivity disorder (ADHD): ERP evidence. Neuropsychopharmacology. 1999;21(2):218–28.
Harmon-Jones E, Barratt ES, Wigg C. Impulsiveness, aggression, reading, and the P300 of the event-related potential. Personal Individ Differ. 1997;22(4):439–45.
Skeem JL, Monahan J. Current directions in violence risk assessment. Curr Dir Psychol Sci. 2011;20(1):38–42.
Wehrmann T, Muller JM. An objective measure of hyperactivity aspects with compressed webcam video. Child Adolesc Psychiatry Ment Health. 2015;9:45.
Collett BR, Ohan JL, Myers KM. Ten-year review of rating scales. V: scales assessing attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2003;42(9):1015–37.
Pasquini M, et al. Detection and treatment of depressive and anxiety disorders among cancer patients: feasibility and preliminary findings from a liaison service in an oncology division. Depress Anxiety. 2006;23(7):441–8.
Pasquini M, et al. Relevance of anger and irritability in outpatients with major depressive disorder. Psychopathology. 2004;37(4):155–60.
Pasquini M, et al. Combining an SSRI with an anticonvulsant in depressed patients with dysphoric mood: an open study. Clin Pract Epidemiol Ment Health. 2007;3:3.
Picardi A, et al. Higher levels of anger and aggressiveness in major depressive disorder than in anxiety and somatoform disorders. J Clin Psychiatry. 2004;65(3):442–3.
Abraham K. Notes on the psychoanalytical investigation of manic-depressive insanity and allied conditions. In: Abraham K, editor. Selected papers of Karl Abraham. London: Hogarth Press; 1948.
Freud S. Mourning and melancholia. In: Strachey J, editor. Standard edition of the complete psychological works of Sigmund Freud, vol. 14. London: Hogarth Press; 1975.
Guidano VF. Complexity of the self. New York: Guilford Press; 1987.
Leopardi G. Zibaldone. Milan: Mondadori Editore; 1996.
Stanghellini G. Dysphoria, vulnerability and identity. An eulogy for anger. Psychopathology. 2000;33(4):198–203.
Fava GA, et al. Hostility and recovery from melancholia. J Nerv Ment Dis. 1986;174(7):414–7.
Fava M, Rosenbaum JF. Anger attacks in depression. Depress Anxiety. 1998;8(Suppl 1):59–63.
Pull CB, et al. The principal dimensions of manifest depression. A factor analysis of manifest depressive symptomatology. Neuropsychobiology. 1979;5(4):207–12.
Overall JE, Hollister LE. Phenomenological classification of depressive disorders. J Clin Psychol. 1980;36(2):372–7.
Riley WT, Treiber FA, Woods MG. Anger and hostility in depression. J Nerv Ment Dis. 1989;177(11):668–74.
Posternak MA, Zimmerman M. Anger and aggression in psychiatric outpatients. J Clin Psychiatry. 2002;63(8):665–72.
Sato T, et al. Frequency of manic symptoms during a depressive episode and unipolar ‘depressive mixed state’ as bipolar spectrum. Acta Psychiatr Scand. 2003;107(4):268–74.
Koh KB, Kim CH, Park JK. Predominance of anger in depressive disorders compared with anxiety disorders and somatoform disorders. J Clin Psychiatry. 2002;63(6):486–92.
Piacentino D, et al. The Association of anger with symptom subtypes in severe obsessive-compulsive disorder outpatients. Psychopathology. 2016;49(1):40–6.
Carni S, et al. Intrapsychic and interpersonal guilt: a critical review of the recent literature. Cogn Process. 2013;14(4):333–46.
McElroy SL, Phillips KA, Keck PE Jr. Obsessive compulsive spectrum disorder. J Clin Psychiatry. 1994;55(Suppl):33–51. discussion 52-3
Hansen DJ, St Lawrence JS, Christoff KA. Effects of interpersonal problem-solving training with chronic aftercare patients on problem-solving component skills and effectiveness of solutions. J Consult Clin Psychol. 1985;53:167–74.
Shure MB, Spivack G. Interpersonal problem solving in young children: a cognitive approach to prevention. Am J Community Psychol. 1982;10:341–56.
Intagliata J. Increasing the interpersonal problem-solving skills of an alcoholic population. J Consult Clin Psychol. 1978;46:489–98.
Platt JJ, McKim P, Husband SD. TIPS: training in interpersonal problem solving: enhanced health promotion and AIDS prevention program. Trainer’s Manual: Camden, University of Medicine and Dentistry of New Jersey; 1990.
Baer RA, Nietzel MT. Cognitive and behavioral treatment of impulsivity in children: a meta-analytic review of the outcome literature. J Clin Child Psychol. 1991;20:400–12.
Edmondson CB, Conger JC. A review of treatment efficacy for individuals with anger problems: conceptual, assessment, and methodological issues. Clin Psychol Rev. 1996;16(3):251–75.
Del Vecchio T, O'Leary KD. Effectiveness of anger treatments for specific anger problems: a meta-analytic review. Clin Psychol Rev. 2004;24(1):15–34.
Saini M. A meta-analysis of the psychological treatment of anger: developing guidelines for evidence-based practice. J Am Acad Psychiatry Law. 2009;37(4):473–88.
Paul GL. Strategy of outcome research in psychotherapy. J Consult Psychol. 1967;31(2):109–18.
Marchand WR. Neural mechanisms of mindfulness and meditation: evidence from neuroimaging studies. World J Radiol. 2014;6(7):471–9.
Fournier JC, Price RB. Psychotherapy and neuroimaging. Focus (Am Psychiatr Publ). 2014;12(3):290–8.
Malone RP, et al. A double-blind placebo-controlled study of lithium in hospitalized aggressive children and adolescents with conduct disorder. Arch Gen Psychiatry. 2000;57(7):649–54.
Campbell M, et al. Lithium in hospitalized aggressive children with conduct disorder: a double-blind and placebo-controlled study. J Am Acad Child Adolesc Psychiatry. 1995;34(4):445–53.
Tariot PN, et al. Efficacy and tolerability of carbamazepine for agitation and aggression in dementia. Am J Psychiatry. 1998;155(1):54–61.
Donovan SJ, et al. Divalproex treatment for youth with explosive temper and mood lability: a double-blind, placebo-controlled crossover design. Am J Psychiatry. 2000;157(5):818–20.
Goldstein MR, Mascitelli L. Is violence in part a lithium deficiency state? Med Hypotheses. 2016;89:40–2.
Coccaro EF, Kavoussi RJ. Fluoxetine and impulsive aggressive behavior in personality-disordered subjects. Arch Gen Psychiatry. 1997;54(12):1081–8.
McDougle CJ, et al. A double-blind, placebo-controlled study of fluvoxamine in adults with autistic disorder. Arch Gen Psychiatry. 1996;53(11):1001–8.
Vartiainen H, et al. Citalopram, a selective serotonin reuptake inhibitor, in the treatment of aggression in schizophrenia. Acta Psychiatr Scand. 1995;91(5):348–51.
Nischal A, Tripathi A, Trivedi JK. Suicide and antidepressants: what current evidence indicates. Mens Sana Monogr. 2012;10(1):33–44.
Katz IR, et al. Comparison of risperidone and placebo for psychosis and behavioral disturbances associated with dementia: a randomized, double-blind trial. Risperidone Study Group. J Clin Psychiatry. 1999;60(2):107–15.
De Deyn PP, et al. A randomized trial of risperidone, placebo, and haloperidol for behavioral symptoms of dementia. Neurology. 1999;53(5):946–55.
McDougle CJ, et al. A double-blind, placebo-controlled study of risperidone in adults with autistic disorder and other pervasive developmental disorders. Arch Gen Psychiatry. 1998;55(7):633–41.
Findling RL, et al. A double-blind pilot study of risperidone in the treatment of conduct disorder. J Am Acad Child Adolesc Psychiatry. 2000;39(4):509–16.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Bersani, F.S., Pasquini, M. (2018). The “Outer Dimensions”: Impulsivity, Anger/Aggressiveness, Activation. In: Biondi, M., Pasquini, M., Picardi, A. (eds) Dimensional Psychopathology. Springer, Cham. https://doi.org/10.1007/978-3-319-78202-7_7
Download citation
DOI: https://doi.org/10.1007/978-3-319-78202-7_7
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-78201-0
Online ISBN: 978-3-319-78202-7
eBook Packages: MedicineMedicine (R0)